Safety Study of ADV-specific T-cells in Paediatric Patients Post Allo-HSCT

NCT01822093 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

ADV Infection Post Allo-HSCT

Interventions

BIOLOGICAL: Cytovir-ADV

Sponsor

Cell Medica Ltd

Collaborators

[object Object]